1. To register, press the "Login, Get Started, or Register" button.
2. Sign in with your scai.org username and password. If you don't have an account, click “Set Up Your Login.”
3. Once registered, you will see a screen where you can add the webinar to your calendar.

You may continue to register after the series has started. All registrants receive access to past session recordings and automatic reminders for up-coming sessions so you won't miss the live webinars.

If you have already registered, choose "Log In" or "Get Started" to access recorded content.

All webinars are from 7-8 pm Eastern Time, 6-7 pm Central Time, 5-6 pm Mountain Time, 4-5 pm Pacific Time.

January 25 | Defining and Treating Complex CAD: An Overview (Recording available)  
February 4 | The Importance of Intravascular Imaging and Physiology in Treating Complex CAD (Recording available)  
Feburary 18 | Treating Complex Coronary Anatomy 1 (Recording available)  
March 4 | Treating Complex Coronary Anatomy 2
March 18 | Treating Patients with CAD and Complex Physiology 
April 1 | Optimizing PCI Facilities: Ambulatory Surgical Centers v. Hospitals

For a full agenda, please see below.

This activity is supported by unrestricted educational grants from Abbott, Asahi, Boston Scientific, Medtronic, and Shockwave Medical. No in-kind commercial support was received.

	Ziad A. Ali, MD, PhD		Emmanouil S. Brilakis, MD, PhD, FSCAI
	Kevin Croce, MD, PhD, FSCAI		George D. Dangas, MD, PhD, FSCAI
	J. Aaron Grantham, MD, fSCAI		Cindy L. Grines, MD, MSCAI
	Timothy D. Henry, MD, MSCAI		Farouc A. Jaffer, MD, PhD, FSCAI
	Dimitrios Karmpaliotis, MD, FSCAI		Kathleen Kearny, MD, FSCAI
	Ajay Kirtane, MD, FSCAI		William L. Lombardi, MD, FSCAI
	Ehtisham Mahmud, MD, FSCAI		Anbukarasi Maran, MD, FSCAI
	Robert F. Riley, MD, FSCAI		Jennifer Tremmel, MD, FSCAI
	Alexander G. Truesdell, MD, FSCAI

Brought to you by the SCAI Ischemic Heart Disease Council:  

January 25 | Defining and Treating Complex CAD: An Overview

• Introduction, Robert F. Riley, MD, FSCAI
• Defining the Complex, Higher-Risk CAD Population, Ajay Kirtane, MD, FSCAI
• A HEART Team Approach to Treating Complex CAD, Farouc A. Jaffer, MD, PhD, FSCAI
• Surgical Turndowns, J. Aaron Grantham, MD, FSCAI
• Discussion with Kathleen Kearney, MD, FSCAI

February 4 | The Importance of Intravascular Imaging and Physiology in Treating Complex CAD 

• Introduction, Robert F. Riley, MD, FSCAI
• How Intravascular Imaging Is Used In Treating Complex CAD, Emmanouil S. Brilakis, MD, PhD, FSCAI
• The Role Of Coronary Physiology In Diagnosing And Treating Complex CAD, Jennifer Tremmel, MD, FSCAI
• Discussion

Feburary 18 | Treating Complex Coronary Anatomy 1

• Introduction, Robert F. Riley, MD, FSCAI
• Treating Bifurcation Lesions, George D. Dangas, MD, PhD, FSCAI
• Treating Left Main Lesions, Ehtisham Mahmud, MD, FSCAI
• Treating In-stent Restenosis, Kevin Croce, MD, PhD, FSCAI
• Discussion

March 4 | Treating Complex Coronary Anatomy 2

• Introduction and Dealing With Calcified Coronary Lesions, Robert F. Riley, MD, FSCAI
• Treating Saphenous Vein Graft Lesions, Cindy L. Grines, MD, MSCAI
• CTO PCI, Dimitrios Karmpaliotis, MD, FSCAI
• Discussion with William L. Lombardi, MD, FSCAI

March 18 | Treating Patients with CAD and Complex Physiology 

• Introduction, Robert F. Riley, MD, FSCAI
• Treating CAD in Patients With Renal Disease, Ziad A. Ali, MD, PhD
• Treating CAD in Patients With Diabetes, Anbukarasi Maran, MD, FSCAI
• Navigating PCI In Patients With Reduced LV Function, Alexander G. Truesdell, MD, FSCAI
• Discussion

April 1 | Optimizing PCI Facilities: Ambulatory Surgical Centers v. Hospitals

• Introduction, Robert F. Riley, MD, FSCAI
• Patient and Lesion Subsets Appropriate for ASCs, Timothy D. Henry, MD, MSCAI
• Patient and Lesion Subsets Appropriate for Hospitals, TBD
• Discussion

Learning Objectives
At the end of this webinar series, participants will be able to:  
1. Define complex coronary artery disease.  
2. Review imaging modalities to identify complex physiology and diagnose accurately.  
3. Discuss procedural techniques for complex lesions and anatomy.   
4. Evaluate therapeutic strategies for patients with multiple comorbidities.  
5. Compare patients who are candidates for ambulatory surgical centers versus hospitals.  

Accreditation Statement
The Society for Cardiovascular Angiography and Interventions is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation
The Society for Cardiovascular Angiography and Interventions designates this live activity for a maximum of 6.0 AMA PRA Category 1 Credit^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 6.0 medical knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Successful Completion
Participate in the webinars and complete each webinar evaluation to obtain credit for that webinar. 

Individuals in control of content disclosed the following relationships with ineligible companies during the content development phase of this activity.

Planner:
Robert Riley: Advisory board and speaker with Abbott. Advisory board with Abiomed. Advisory board, consulting and speaker with Boston Scientific Corp. and Medtronic.

Planning Oversight/Approvers:
Sahil Parikh, Education Committee Chair: Advisory board for Abbott, Boston Scientific Corp., Cardiovascular Systems, Inc., and Medtronic. Consulting with Terumo, Merill Lifesciences, and eFemoral. Principal investigator with Shockwave Medical, TriReme Medical, and Surmodics.
Poonam Velagapudi, Education Committee Co-Chair: No relevant relationships with ineligible companies to disclose.
Mauricio Cohen, IHD Council Chair: Consulting and speaker for Abiomed. Consulting for Merit Medical and Medtronic. Stocks with Accumed Radial Systems.

Faculty:
Emmanouil Brilakis: Consulting and speaker for Abbott Vascular, Amgen, Biotronik, Boston Scientific, ControlRad, Cardiovascular System, Inc., and GE Healthcare.
Kevin Croce: Advisory board, principal investigator, and consulting with Abbott. Advisory board and consulting with Boston Scientific Corp. and Biotronik.
George Dangas: Principal investigator with Abbott and Boston Scientific Corp.
J. Aaron Grantham: Principal investigator with Boston Scientific. Consulting for Boston Scientific, and Asahi-Intecc. Stock with Corindus.
Cindy Grines: Advisory Board for Abiomed.
Timothy Henry: No relevant financial relationships with ineligible companies to disclose.
Farouc Jaffer: Advisory board with Biotronik. Advisory board and speaker with Boston Scientific Corp. Principal investigator with Canon U.S.A. Stocks with Intravascular Imaging. Consulting with Magenta Medical. Principal investigator with Shockwave and Teleflex.
Dimitrios Karmpaliotis: Equity with Saranas and Soundbite. Honoraria from Boston Scientific and Abbott Vascular.
Kathleen Kearney: Consulting for Boston Scientific Corp., Cardiovascular Systems, Inc., and Teleflex, Inc.
Ajay Kirtane: Principal Investigator for Medtronic, Boston Scientific, Abbott Vascular, Abiomed, CSI, CathWorks, Siemens, Philips, and ReCor Medical.
William Lombardi: Advisory board and consulting with Boston Scientific Corp. Consulting, Royalties with Asahi Intecc. Consulting with Teleflex.
Ehtisham Mahmud: Principal investigator and speaker with Abbott. Speaker for Medtronic.
Sunil Rao: No relevant financial relationships with ineligible companies to disclose.
Robert Riley: Advisory board and speaker with Abbott. Advisory board with Abiomed. Advisory board, consulting and speaker with Boston Scientific Corp. and Medtronic.
Jennifer Tremmel: Advisory board and principal investigator with Boston Scientific Corp.

CME Oversight Committee, Faculty COI Mitigation:
Patricia Best, William Penny, and Elissa Alton: No relevant relationships with ineligible companies to disclose.

SCAI Staff:
No relevant relationships with ineligible companies to disclose.

© 2021-2022 Society for Cardiovascular Angiography and Interventions (SCAI). All rights reserved.